Advertisement
UK markets close in 3 hours 57 minutes

  • FTSE 100

    8,118.85
    +39.99 (+0.49%)
     

  • FTSE 250

    19,814.81
    +212.83 (+1.09%)
     

  • AIM

    755.50
    +2.38 (+0.32%)
     

  • GBP/EUR

    1.1663
    +0.0007 (+0.06%)
     

  • GBP/USD

    1.2514
    +0.0003 (+0.03%)
     

  • Bitcoin GBP

    51,229.74
    +191.55 (+0.38%)
     

  • CMC Crypto 200

    1,384.79
    -11.75 (-0.84%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.17
    +0.60 (+0.72%)
     

  • GOLD FUTURES

    2,358.70
    +16.20 (+0.69%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,065.59
    +148.31 (+0.83%)
     

  • CAC 40

    8,045.76
    +29.11 (+0.36%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Hikma says to buy Egyptian pharma firm EIMC United

Reuters - UK Focus

Sept 8 (Reuters) - Hikma Pharmaceutical Plc said it would buy nearly the entire share capital of EIMC United Pharmaceuticals, a drugmaker specialising in oncology products, from a consortium of shareholders to strengthen its position in the Egyptian market.

Hikma, which makes and markets branded and non-branded generic and injectable drugs, did not disclose the value of the deal. Hikma's Egyptian unit has presently a 2 percent market share in that country. (Reporting by Esha Vaish in Bengaluru; Editing by Gopakumar Warrier)